[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck

Upstate Institutional Review Board (IRB) Number:

501348

Study/Protocol ID:

RTOG-1216

Study Phase:

II/III

Patient Age Group:

Adults

Principal Investigator:

Seung Shin Hahn, MD

What is involved if I participate?

  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes

Where will the study take place?

Oneida Medical Oncology and Radiation Oncology
Oswego Medical Oncology and Radiation Oncology
The Hill Medical Center Radiation Oncology

ClinicalTrials.Gov ID:

NCT01810913

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Laine Abernathy
Phone: 315-464-6528
Email: abernatl@upstate.edu

Return to Previous Page || Search Again

Top